Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Measurement Challenges for CAR-T Biomanufacturing

CAR-T cell therapies are demonstrating tantalizing clinical efficacy in early trials against blood cancers, and are changing the paradigm for standard of care. However, for CAR-T therapies to move into routine clinical use, their manufacture must become robust, reliable, and cost-efficient. The regulatory framework for approval of these CAR-T therapies must also accommodate more flexible, 'right-sized' manufacturing processes. On Friday, January 29, 2016, NIST will convene industry, government and academic stakeholders to address industry-wide challenges to the production of CAR-T therapies. Join thought-leaders and policy-makers as we develop strategies to break down the barriers for manufacture of these exciting new therapies.

Sponsors

Missing media item.

A complete agenda will be posted at https://www.ibbr.umd.edu/NISTCART.

Keynote speaker:
Dr. Bruce Levine
Abramson Cancer Center
University of Pennsylvania

Speakers to include representatives from the FDA, MedImmune, bluebird bio, National Cancer Institute, MaxCyte, and Novartis.

Created December 10, 2015, Updated September 21, 2016